Golareh Agha1, Michael M Mendelson2,3,4, Cavin K Ward-Caviness5,6, Roby Joehanes2,7, TianXiao Huan8, Rahul Gondalia9, Elias Salfati10, Jennifer A Brody11, Giovanni Fiorito12, Jan Bressler13, Brian H Chen14, Symen Ligthart15, Simonetta Guarrera12, Elena Colicino16, Allan C Just16, Simone Wahl17, Christian Gieger17, Amy R Vandiver18, Toshiko Tanaka14, Dena G Hernandez19, Luke C Pilling20, Andrew B Singleton19, Carlotta Sacerdote21, Vittorio Krogh22, Salvatore Panico23, Rosario Tumino24, Yun Li25, Guosheng Zhang26, James D Stewart27, James S Floyd11, Kerri L Wiggins11, Jerome I Rotter28, Michael Multhaup18, Kelly Bakulski29, Steven Horvath30, Philip S Tsao10, Devin M Absher31, Pantel Vokonas32, Joel Hirschhorn33,34, M Daniele Fallin35, Chunyu Liu36, Stefania Bandinelli37, Eric Boerwinkle38,39, Abbas Dehghan40, Joel D Schwartz41, Bruce M Psaty42,43, Andrew P Feinberg44, Lifang Hou45, Luigi Ferrucci46, Nona Sotoodehnia47, Giuseppe Matullo12, Annette Peters48,49, Myriam Fornage50, Themistocles L Assimes51, Eric A Whitsel52, Daniel Levy2,3, Andrea A Baccarelli1. 1. Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York (G.A., A.A.B.). 2. Population Sciences Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD (M.M.M., D.L., R.J.). 3. Framingham Heart Study, MA (M.M.M., D.L.). 4. Department of Cardiology, Boston Children's Hospital, MA (M.M.M.). 5. National Health and Environmental Effects Research Laboratory, Environmental Public Health Division, Chapel Hill, NC (C.K.W.C.). 6. Institute of Epidemiology II, Helmholtz Institute, Ingolstaedter Landstrasse 1, Neuherberg, Germany (C.K.W.C.). 7. Hebrew SeniorLife, Harvard Medical School, Boston, MA (R.J.). 8. The Population Sciences Branch, Division of Intramural Research, National Heart, Lung and Blood Institute, Bethesda, MD (T.X.H.). 9. Department of Epidemiology (R.G.), University of North Carolina, Chapel Hill. 10. Department of Medicine, Stanford University School of Medicine, CA (E.S., P.S.T.). 11. Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle (J.A.B., J.S.F., K.L.W.). 12. Italian Institute for Genomic Medicine (IIGM/HuGeF) and Department of Medical Sciences, University of Turin, Italy (G.F., S.G., G.M.). 13. Human Genetics Center, School of Public Health, University of Texas Health Science Center at Houston (J.B.). 14. Translational Gerontology Branch, National Institute on Aging, National Institutes of Health, Baltimore, MD (B.H.C., T.T.). 15. Department of Epidemiology, Erasmus MC University Medical Center, Rotterdam, the Netherlands (S.L.). 16. Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY (E.C., A.C.J.). 17. Research Unit Molecualr Epidemiology, Helmholtz Zentrum München, Germany (S.W., C.G.). 18. Center for Epigenetics, Johns Hopkins University School of Medicine, Baltimore, MD (A.R.V., M.M.). 19. Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD (D.G.H., A.B.S.). 20. Epidemiology and Public Health Group, University of Exeter Medical School, United Kingdom (L.C.P.). 21. Unit of Cancer Epidemiology, Città della Salute e della Scienza University-Hospital and Center for Cancer Prevention (CPO), Turin, Italy (C.S.). 22. Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy (V.K.). 23. Dipartimento di Medicina Clinica e Chirurgia, Federico II University, Naples, Italy (S.P.). 24. Cancer Registry And Histopathology Department, Civic- M.P. Arezzo2 Hospital, Asp Ragusa, Italy (R.T.). 25. Department of Genetics, Department of Biostatistics, Department of Computer Science (Y.L.), University of North Carolina, Chapel Hill. 26. Curriculum in Bioinformatics and Computational Biology, Department of Genetics, and Department of Statistics (G.Z.), University of North Carolina, Chapel Hill. 27. Carolina Population Center and Department of Epidemiology (J.D.S.), University of North Carolina, Chapel Hill. 28. The Institute for Translational Genomics and Population Sciences, Departments of Pediatrics and Medicine, LABioMed at Harbor-UCLA Medical Center, Torrance, CA (J.I.R.). 29. Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor (K.B.). 30. Department of Human Genetics, David Geffen School of Medicine, University of California Los Angeles (S.H.). 31. HudsonAlpha institute of Biotechnology, Huntsville, AL (D.M.A.). 32. VA Normative Aging Study, VA Boston Healthcare System, Department of Medicine, Boston University School of Medicine, MA (P.V.). 33. Department of Medicine, Division of Endocrinology, Boston Children's Hospital, MA (J.H.). 34. Departments of Medicine and Pediatrics, Harvard Medical School, Boston, MA (J.H.). 35. Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (M.D.F.). 36. Department of Biostatistics, Boston University School of Public Health, MA (C.L.). 37. Azienda Sanitaria, USL Centro Firenze, Italy (S.B.). 38. Human Genetics Center, School of Public Health, The University of Texas Health Science Center at Houston (E.B.). 39. Human Genome Sequencing Center, Baylor College of Medicine, TX (E.B.). 40. Department of Epidemiology and Biostatistics, MRC-PHE Centre for Environment & Health, School of 346 Public Health, Imperial College London, United Kingdom (A.D.). 41. Department of Epidemiology and Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA (J.D.S.). 42. Cardiovascular Health Research Unit, Departments of Medicine, Epidemiology, and Health Services, University of Washington, Seattle (B.M.P.). 43. Kaiser Permanente Washington Health Research Institute, Seattle (B.M.P.). 44. Departments of Medicine, Biomedical Engineering, and Mental Health, Johns Hopkins University, Baltimore, MD (A.P.F.). 45. Center for Population Epigenetics, Robert H. Lurie Comprehensive Cancer Center and Department of Preventive Medicine, Northwestern University, Feinberg School of Medicine, Chicago, IL (L.H.). 46. Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, MD (L.F.). 47. Division of Cardiology, Departments of Medicine and Epidemiology, Cardiovascular Health Research Unit, University of Washington, Seattle (N.S.). 48. Helmholtz Zentrum München, Institute of Epidemiology, Neuherberg, Germany; German Research Center for Cardiovascular Disease (DzHK e.V. - partner site Munich), Germany (A.P.). 49. Ludwig-Maximilians University, Institute for Biometry, Medical Information Science and Epidemiology, Munich, Germany (A.P.). 50. Brown Foundation Institute of Molecular Medicine McGovern Medical School, and Human Genetics Center, School of Public Health, The University of Texas Health Science Center at Houston (M.F.). 51. Department of Medicine (Cardiovascular Medicine), and Department of Health Research & Policy, Stanford University School of Medicine, CA (T.L.A.). 52. Department of Epidemiology, Gillings School of Global Public Health, and Department of Medicine, School of Medicine, University of North Carolina, Chapel Hill (E.A.W.).
Abstract
BACKGROUND: DNA methylation is implicated in coronary heart disease (CHD), but current evidence is based on small, cross-sectional studies. We examined blood DNA methylation in relation to incident CHD across multiple prospective cohorts. METHODS: Nine population-based cohorts from the United States and Europe profiled epigenome-wide blood leukocyte DNA methylation using the Illumina Infinium 450k microarray, and prospectively ascertained CHD events including coronary insufficiency/unstable angina, recognized myocardial infarction, coronary revascularization, and coronary death. Cohorts conducted race-specific analyses adjusted for age, sex, smoking, education, body mass index, blood cell type proportions, and technical variables. We conducted fixed-effect meta-analyses across cohorts. RESULTS: Among 11 461 individuals (mean age 64 years, 67% women, 35% African American) free of CHD at baseline, 1895 developed CHD during a mean follow-up of 11.2 years. Methylation levels at 52 CpG (cytosine-phosphate-guanine) sites were associated with incident CHD or myocardial infarction (false discovery rate<0.05). These CpGs map to genes with key roles in calcium regulation (ATP2B2, CASR, GUCA1B, HPCAL1), and genes identified in genome- and epigenome-wide studies of serum calcium (CASR), serum calcium-related risk of CHD (CASR), coronary artery calcified plaque (PTPRN2), and kidney function (CDH23, HPCAL1), among others. Mendelian randomization analyses supported a causal effect of DNA methylation on incident CHD; these CpGs map to active regulatory regions proximal to long non-coding RNA transcripts. CONCLUSION: Methylation of blood-derived DNA is associated with risk of future CHD across diverse populations and may serve as an informative tool for gaining further insight on the development of CHD.
BACKGROUND: DNA methylation is implicated in coronary heart disease (CHD), but current evidence is based on small, cross-sectional studies. We examined blood DNA methylation in relation to incident CHD across multiple prospective cohorts. METHODS: Nine population-based cohorts from the United States and Europe profiled epigenome-wide blood leukocyte DNA methylation using the Illumina Infinium 450k microarray, and prospectively ascertained CHD events including coronary insufficiency/unstable angina, recognized myocardial infarction, coronary revascularization, and coronary death. Cohorts conducted race-specific analyses adjusted for age, sex, smoking, education, body mass index, blood cell type proportions, and technical variables. We conducted fixed-effect meta-analyses across cohorts. RESULTS: Among 11 461 individuals (mean age 64 years, 67% women, 35% African American) free of CHD at baseline, 1895 developed CHD during a mean follow-up of 11.2 years. Methylation levels at 52 CpG (cytosine-phosphate-guanine) sites were associated with incident CHD or myocardial infarction (false discovery rate<0.05). These CpGs map to genes with key roles in calcium regulation (ATP2B2, CASR, GUCA1B, HPCAL1), and genes identified in genome- and epigenome-wide studies of serum calcium (CASR), serum calcium-related risk of CHD (CASR), coronary artery calcified plaque (PTPRN2), and kidney function (CDH23, HPCAL1), among others. Mendelian randomization analyses supported a causal effect of DNA methylation on incident CHD; these CpGs map to active regulatory regions proximal to long non-coding RNA transcripts. CONCLUSION: Methylation of blood-derived DNA is associated with risk of future CHD across diverse populations and may serve as an informative tool for gaining further insight on the development of CHD.
Authors: Palle G Laustsen; Steven J Russell; Lei Cui; Amelia Entingh-Pearsall; Martin Holzenberger; Ronglih Liao; C Ronald Kahn Journal: Mol Cell Biol Date: 2006-12-22 Impact factor: 4.272
Authors: Melissa A Richard; Tianxiao Huan; Symen Ligthart; Rahul Gondalia; Min A Jhun; Jennifer A Brody; Marguerite R Irvin; Riccardo Marioni; Jincheng Shen; Pei-Chien Tsai; May E Montasser; Yucheng Jia; Catriona Syme; Elias L Salfati; Eric Boerwinkle; Weihua Guan; Thomas H Mosley; Jan Bressler; Alanna C Morrison; Chunyu Liu; Michael M Mendelson; André G Uitterlinden; Joyce B van Meurs; Oscar H Franco; Guosheng Zhang; Yun Li; James D Stewart; Joshua C Bis; Bruce M Psaty; Yii-Der Ida Chen; Sharon L R Kardia; Wei Zhao; Stephen T Turner; Devin Absher; Stella Aslibekyan; John M Starr; Allan F McRae; Lifang Hou; Allan C Just; Joel D Schwartz; Pantel S Vokonas; Cristina Menni; Tim D Spector; Alan Shuldiner; Coleen M Damcott; Jerome I Rotter; Walter Palmas; Yongmei Liu; Tomáš Paus; Steve Horvath; Jeffrey R O'Connell; Xiuqing Guo; Zdenka Pausova; Themistocles L Assimes; Nona Sotoodehnia; Jennifer A Smith; Donna K Arnett; Ian J Deary; Andrea A Baccarelli; Jordana T Bell; Eric Whitsel; Abbas Dehghan; Daniel Levy; Myriam Fornage Journal: Am J Hum Genet Date: 2017-11-30 Impact factor: 11.025
Authors: Eugene Andres Houseman; William P Accomando; Devin C Koestler; Brock C Christensen; Carmen J Marsit; Heather H Nelson; John K Wiencke; Karl T Kelsey Journal: BMC Bioinformatics Date: 2012-05-08 Impact factor: 3.169
Authors: Simonetta Guarrera; Giovanni Fiorito; N Charlotte Onland-Moret; Alessia Russo; Claudia Agnoli; Alessandra Allione; Cornelia Di Gaetano; Amalia Mattiello; Fulvio Ricceri; Paolo Chiodini; Silvia Polidoro; Graziella Frasca; Monique W M Verschuren; Jolanda M A Boer; Licia Iacoviello; Yvonne T van der Schouw; Rosario Tumino; Paolo Vineis; Vittorio Krogh; Salvatore Panico; Carlotta Sacerdote; Giuseppe Matullo Journal: Clin Epigenetics Date: 2015-12-24 Impact factor: 6.551
Authors: Naisi Zhao; Mengyuan Ruan; Devin C Koestler; Jiayun Lu; Carmen J Marsit; Karl T Kelsey; Elizabeth A Platz; Dominique S Michaud Journal: Epigenetics Date: 2021-05-19 Impact factor: 4.528
Authors: Jiantao Ma; Casey M Rebholz; Kim V E Braun; Lindsay M Reynolds; Stella Aslibekyan; Rui Xia; Niranjan G Biligowda; Tianxiao Huan; Chunyu Liu; Michael M Mendelson; Roby Joehanes; Emily A Hu; Mara Z Vitolins; Alexis C Wood; Kurt Lohman; Carolina Ochoa-Rosales; Joyce van Meurs; Andre Uitterlinden; Yongmei Liu; Mohamed A Elhadad; Margit Heier; Melanie Waldenberger; Annette Peters; Elena Colicino; Eric A Whitsel; Antoine Baldassari; Sina A Gharib; Nona Sotoodehnia; Jennifer A Brody; Colleen M Sitlani; Toshiko Tanaka; W David Hill; Janie Corley; Ian J Deary; Yan Zhang; Ben Schöttker; Hermann Brenner; Maura E Walker; Shumao Ye; Steve Nguyen; Jim Pankow; Ellen W Demerath; Yinan Zheng; Lifang Hou; Liming Liang; Alice H Lichtenstein; Frank B Hu; Myriam Fornage; Trudy Voortman; Daniel Levy Journal: Circ Genom Precis Med Date: 2020-06-11